Aaron Goldberg

Dr. Aaron Goldberg is an Assistant Attending Physician at Memorial Sloan Kettering Cancer Center (MSKCC), and Assistant Professor of Medicine at Weill Cornell Medical College in New York City. He received a bachelor’s degree magna cum laude with highest honors in History and Science from Harvard University. He earned his MD from Weill Cornell Medical College and PhD from Rockefeller University, where he studied epigenetic mechanisms of gene regulation with Dr. C. David Allis. He completed his residency in internal medicine at Brigham and Women’s Hospital, followed by a fellowship in hematology and medical oncology at MSKCC under the mentorship of Dr. Martin Tallman. In his current role, Dr. Goldberg cares for leukemia patients, leads translational research projects, and serves as the principal investigator for multiple clinical trials. His research interests focus on the development of novel therapeutic approaches for acute myeloid leukemia, including combination therapies to target residual disease, as well as evaluation of real-world outcomes of current therapy and genomic predictors of response. Dr. Goldberg currently serves as a member of the National Comprehensive Cancer Network Guidelines Panel for acute myeloid leukemia. He has received multiple awards, including a Young Investigator Award from the American Society of Clinical Oncology, and an American Society of Hematology Fellow Scholar Award in Clinical Research.